Showing results (221-230 of 288) with videos related to

Sort By:
Pageof 29
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Nature Chemical Biology|October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E Winter, Uwe Rix, Scott M Carlson, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
ACS Pharmacology & Translational Science|April 18, 2024
Illuminating Neuropeptide Y Y4 Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular ToolsJakob Gleixner, Sergei Kopanchuk, Lukas Grätz, et al.
Tree Physiology|October 31, 2018
Standardized protocols and procedures can precisely and accurately quantify non-structural carbohydratesSimon M Landhäusser, Pak S Chow, L Turin Dickman, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Characterisation and Prognostic Implication of Cholestasis After Burn InjuryLorenz Semmler, Georg Semmler, Andreas Langa, et al.
Experimental Hematology|August 30, 2008
Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosisEmir Hadzijusufovic, Laura Rebuzzi, Karoline V Gleixner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Elife|June 1, 2021
Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathologyEric N Anderson, Andrés A Morera, Sukhleen Kour, et al.
Pageof 29